Cargando…
Broad-spectrum antivirals against viral fusion
Effective antivirals have been developed against specific viruses, such as HIV, Hepatitis C virus and influenza virus. This 'one bug–one drug' approach to antiviral drug development can be successful, but it may be inadequate for responding to an increasing diversity of viruses that cause...
Autores principales: | Vigant, Frederic, Santos, Nuno C., Lee, Benhur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554337/ https://www.ncbi.nlm.nih.gov/pubmed/26075364 http://dx.doi.org/10.1038/nrmicro3475 |
Ejemplares similares
-
A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
por: Vigant, Frederic, et al.
Publicado: (2013) -
Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides
por: Mathieu, Cyrille, et al.
Publicado: (2017) -
Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023) -
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019) -
Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)